These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33733300)

  • 1. Assessing the links between childhood trauma, C-reactive protein and response to antidepressant treatment in patients with affective disorders.
    Fischer KF; Simon MS; Elsner J; Dobmeier J; Dorr J; Blei L; Zill P; Obermeier M; Musil R
    Eur Arch Psychiatry Clin Neurosci; 2021 Oct; 271(7):1331-1341. PubMed ID: 33733300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein and response to lurasidone treatment in children and adolescents with bipolar I depression: Results from a placebo-controlled trial.
    Raison CL; Siu C; Pikalov A; Tocco M; Loebel A
    Brain Behav Immun; 2020 Feb; 84():269-274. PubMed ID: 31857217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein and response to lurasidone in patients with bipolar depression.
    Raison CL; Pikalov A; Siu C; Tsai J; Koblan K; Loebel A
    Brain Behav Immun; 2018 Oct; 73():717-724. PubMed ID: 30102967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated C-reactive Protein Levels in Women with Bipolar Disorder may be Explained by a History of Childhood Trauma, Especially Sexual Abuse, Body Mass Index and Age.
    Moraes JB; Maes M; Barbosa DS; Ferrari TZ; Uehara MKS; Carvalho AF; Nunes SOV
    CNS Neurol Disord Drug Targets; 2017; 16(4):514-521. PubMed ID: 28403800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor.
    Hasebe K; Gray L; Bortolasci C; Panizzutti B; Mohebbi M; Kidnapillai S; Spolding B; Walder K; Berk M; Malhi G; Dodd S; Dean OM
    Acta Neuropsychiatr; 2017 Dec; 29(6):337-346. PubMed ID: 28318471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood maltreatment and clinical severity of treatment-resistant depression in a French cohort of outpatients (FACE-DR): One-year follow-up.
    Yrondi A; Aouizerate B; Bennabi D; Richieri R; D'Amato T; Bellivier F; Bougerol T; Horn M; Camus V; Courtet P; Doumy O; Genty JB; Holtzmann J; Lancon C; Leboyer M; Llorca PM; Maruani J; Moirand R; Molière F; Samalin L; Schmitt L; Stephan F; Turecki G; Vaiva G; Walter M; Petrucci J; ; Haffen E; El-Hage W
    Depress Anxiety; 2020 Apr; 37(4):365-374. PubMed ID: 31999402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association Between Adverse Childhood Experiences and Inflammation in Patients with Major Depressive Disorder: A Systematic Review.
    Gill H; El-Halabi S; Majeed A; Gill B; Lui LMW; Mansur RB; Lipsitz O; Rodrigues NB; Phan L; Chen-Li D; McIntyre RS; Rosenblat JD
    J Affect Disord; 2020 Jul; 272():1-7. PubMed ID: 32379599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between childhood physical abuse and clinical severity of treatment-resistant depression in a geriatric population.
    Yrondi A; Arbus C; Bennabi D; D'Amato T; Bellivier F; Bougerol T; Camus V; Courtet P; Doumy O; Genty JB; Holtzmann J; Horn M; Lancon C; Leboyer M; Llorca PM; Maruani J; Moirand R; Molière F; Petrucci J; Richieri R; Samalin L; Stephan F; Vaiva G; Walter M; ; Haffen E; Aouizerate B; El-Hage W
    PLoS One; 2021; 16(4):e0250148. PubMed ID: 33878137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the tryptophan-kynurenine axis in association to therapeutic response in clinically depressed patients undergoing psychiatric rehabilitation.
    Reininghaus B; Riedrich K; Dalkner N; Bengesser SA; Birner A; Platzer M; Hamm C; Gostner JM; Fuchs D; Reininghaus EZ
    Psychoneuroendocrinology; 2018 Aug; 94():25-30. PubMed ID: 29753175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood maltreatment severity is associated with elevated C-reactive protein and body mass index in adults with schizophrenia and bipolar diagnoses.
    Aas M; Dieset I; Hope S; Hoseth E; Mørch R; Reponen E; Steen NE; Laskemoen JF; Ueland T; Aukrust P; Agartz I; Andreassen OA; Melle I
    Brain Behav Immun; 2017 Oct; 65():342-349. PubMed ID: 28619247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls.
    Bai YM; Su TP; Li CT; Tsai SJ; Chen MH; Tu PC; Chiou WF
    Bipolar Disord; 2015 May; 17(3):269-77. PubMed ID: 25257835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia.
    Fond G; Micoulaud-Franchi JA; Faugere M; Boyer L; Faget-Agius C; Lançon C; Richieri R; Cermolacce M
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109800. PubMed ID: 31676465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between inflammatory state and quantity of affective episodes in bipolar disorder.
    Queissner R; Pilz R; Dalkner N; Birner A; Bengesser SA; Platzer M; Fellendorf FT; Kainzbauer N; Herzog-Eberhard S; Hamm C; Reininghaus B; Zelzer S; Mangge H; Mansur RB; McIntyre RS; Kapfhammer HP; Reininghaus EZ
    Psychoneuroendocrinology; 2018 Apr; 90():61-67. PubMed ID: 29433074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial.
    McIntyre RS; Subramaniapillai M; Lee Y; Pan Z; Carmona NE; Shekotikhina M; Rosenblat JD; Brietzke E; Soczynska JK; Cosgrove VE; Miller S; Fischer EG; Kramer NE; Dunlap K; Suppes T; Mansur RB
    JAMA Psychiatry; 2019 Aug; 76(8):783-790. PubMed ID: 31066887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived neurotrophic factor, adiponectin, and proinflammatory markers in various subtypes of depression in young men.
    Su SC; Sun MT; Wen MJ; Lin CJ; Chen YC; Hung YJ
    Int J Psychiatry Med; 2011; 42(3):211-26. PubMed ID: 22439294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: A randomised controlled study.
    Vinberg M; Weikop P; Olsen NV; Kessing LV; Miskowiak K
    Brain Behav Immun; 2016 Oct; 57():53-57. PubMed ID: 27181179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of adverse childhood experiences on adult depression severity and treatment outcomes.
    Giampetruzzi E; Tan AC; LoPilato A; Kitay B; Riva Posse P; McDonald WM; Hermida AP; Crowell A; Hershenberg R
    J Affect Disord; 2023 Jul; 333():233-239. PubMed ID: 37086798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of childhood trauma and correlations between childhood trauma, suicidal ideation, and social support in patients with depression, bipolar disorder, and schizophrenia in southern China.
    Xie P; Wu K; Zheng Y; Guo Y; Yang Y; He J; Ding Y; Peng H
    J Affect Disord; 2018 Mar; 228():41-48. PubMed ID: 29223913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between depressive symptoms, cognitive function, and inflammation in major depression.
    Krogh J; Benros ME; Jørgensen MB; Vesterager L; Elfving B; Nordentoft M
    Brain Behav Immun; 2014 Jan; 35():70-6. PubMed ID: 24016864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.